[1] Park BJ,Wannemuehler KA,Marston BJ,et al.Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS[J].AIDS, 2009,23(4):525-530.
[2] Springer DJ,Billmyre RB,Filler EE,et al.Cryptococcus gattii VGⅢ isolates causing infections in HIV/AIDS patients in Southern California:identification of the local environmental source as arboreal[J]. PLOS Pathogens,2014,10(8):e1004285.
[3] Charlier C, Chrétien F, Baudrimont M,et al.Capsule structure change associated with Cryptococcus neoformans crossing of the blood-brain barrier[J].Am J Pathol,2005,166(2):421-432.
[4] McClelland EE, Perrine WT, Potts WK,et al.Relationship of virulence factor expression to evolved virulence in mouse-passaged Cryptococcus neoformans lines[J].Infect Immun,2005,73(10):7047-7050.
[5] Vu K,Garcia JA,Gelli A.Cryptococcal meningitis and anti-virulence therapeutic strategies[J].Front Microbiol,2019,10:00353(1-7).
[6] Harrison TS. Cryptococcus neoformans and cryptococcosis[J]. J Infect,2000, 41(1):12-17.
[7] 李娟.艾滋病常见真菌性机会感染基因芯片筛查试剂盒的研制[D].郑州:河南中医学院,2014.
[8] Boaz MM, Kalluvya S, Downs JA,et al.Pattern, clinical characteristics, and outcome of meningitis among HIV-infected adults admitted in a tertiary hospital in North Western Tanzania:a cross-sectional study[J].J Trop Med, 2016:6573672.
[9] Ramírez-Crescencio MA, Velásquez-Pérez L, Ramírez-Crescencio MA,et al. Epidemiology and trend of neurological diseases associated to HIV/AIDS. Experience of Mexican patients 1995-2009[J].Clin Neurol Neurosurg,2013,115(8):1322-1325.
[10] Srichatrapimuk S, Sungkanuparph S. Integrated therapy for HIV and cryptococcosis[J].AIDS Res Ther,2016,13:42:1-15.
[11] Perfect JR,Dismukes WE, Dromer F,et al. Clinical practice guidelines for the management of cryptococcal disease:2010 update by the infectious diseases society of America[J].Clin Infect Dis,2010,50(3):291-322.
[12] 吴媛,卢金星. 新型隐球菌分子分型进展[J]. 中国人兽共患病学报,2010, 26(9):867-869.
[13] Michael GR,David JD,Anne H,et al.Serotypes of Cryptococcus neoformans in patients with AIDS[J].J Infect Dis, 1986,153(3):642.
[14] 李竹青,邵经政,廖万清,等.中国致病性新型隐球菌血清型的研究[J].中国皮肤性病学杂志,1987:4-7.
[15] Desnos-Ollivier M, Patel S, Raoux-Barbot D,et al. Cryptococcosis serotypes impact outcome and provide evidence of Cryptococcus neoformans speciation[J],MBio,2015,6(3):e00311-15.
[16] 边富宁,吴媛,于栓宝,等. 广西贵港地区2009-2012年新生隐球菌和格特隐球菌临床分离株基因分型与毒力特性研究[J].中华流行病学杂志,2015,36(5):491-495.
[17] 戚建明,陈江汉,杨军. 129株新型隐球菌基因型及感染人群研究[J]. 中国感染与化疗杂志,2013,13(6):481-485.
[18] Khayhan K,Hagen F,Pan W,et al. Geographically structured populations of Cryptococcus neoformans variety grubii in Asia correlate with HIV status and show a clonal population structure[J]. PloS one,2013,8(9):e7222(1-14).
[19] 郭鹏豪,黄汉,刘秀丽,等. 广东地区新型隐球菌多位点序列分型及临床特点分析[J].中华医院感染学杂志,2016, 26(22):5072-5075.
[20] Maestrale C, Masia M, Pintus D, et al. Genetic and pathological characteristics of Cryptococcus gattii and Cryptococcus neoformans var. neoformans from meningoencephalitis in autochthonous goats and mouflons, Sardinia, Italy[J]. Vet Microbiol, 2015, 177:409-413.
[21] 张嗣兴,寇建琼, 李惠琴,等. 艾滋病患者深部真菌感染菌群分布及其耐药性[J].中国感染控制杂志,2011,10(5):351-353.
[22] 陶星辰,尚秋菊,刘晓英,等. 云南省部分地区鸽粪中新型隐球菌的分离与鉴定[J].中国病原生物学杂志,2014,9(10):873-876.
[23] 陶星辰,程攀,苏鸿雁. 云南省部分地区鸽粪中新型隐球菌格鲁比变种微卫星分型分析[J]. 中国病原生物学杂志,2016,11(2):107-109.
[24] 张米,雷素云,高丽.艾滋病患者培养检出新型隐球菌的分布特点及其耐药分析[J].世界最新医学信息文摘,2015,15(2):102-103.
[25] 樊红丽,高丽,毛小琴,等.云南省艾滋病患者分离新生隐球菌的药物敏感性检测与分析[J].中国感染控制杂志,2019,8(4):340-343.
[26] 樊红丽,高丽,杨翠先,等.云南省新型隐球菌药物敏感流行病学折点的建立[J].重庆医学,2019,48(18):3188-3190,3193. |
